Abstract
The clinical and pathological findings of plasmablastic lymphoma (PBL) have been described in the literature but the etiology is not well established, and treatment options are poorly defined. We reviewed patients with PBL in our institution to characterize the clinicopathologic features in our patient population. In this retrospective analysis from a single academic institution, five patients with PBL were identified and analyzed. Human immunodeficiency virus and human herpesvirus 8 (HHV-8) were identified in 40% (two out of five) and 80% (four out of five) of these patients, respectively. Central nervous system (CNS) involvement was identified in four out of five (80%) patients. Interestingly, three out of five patients had a concurrent or preceding second primary malignancy including small lymphocytic lymphoma, endometrial cancer, and nonsmall cell lung cancer. Most of the patients had advanced disease and a poor performance status at diagnosis. Only two of the patients received systemic chemotherapy with an initial partial response. All five patients died; the median overall survival was 1 month. Our experience in patients with PBL indicates that CNS involvement is more common than reported in the literature. Coexistence of a second primary malignancy may be frequent, and prognosis remains dismal with standard lymphoma therapy. Lastly, the role of HHV-8 in the etiopathogenesis needs further trials.
Similar content being viewed by others
References
Armstrong R, Bradrick J, Liu YC (2007) Spontaneous regression of an HIV-associated plasmablastic lymphoma in the oral cavity: a case report. J Oral Maxillofac Surg 65(7):1361–1364. doi:10.1016/j.joms.2005.12.039
Borenstein J, Pezzella F, Gatter KC (2007) Plasmablastic lymphomas may occur as post-transplant lymphoproliferative disorders. Histopathology 51(6):774–777. doi:10.1111/j.1365-2559.2007.02870.x
Borrero JJ, Pujol E, Perez S, Merino D, Montano A, Rodriguez FJ (2002) Plasmablastic lymphoma of the oral cavity and jaws. AIDS 16(14):1979–1980. doi:10.1097/00002030-200209270-00022
Brown RS, Campbell C, Lishman SC, Spittle MF, Miller RF (1998) Plasmablastic lymphoma: a new subcategory of human immunodeficiency virus-related non-Hodgkin’s lymphoma. Clin Oncol (R Coll Radiol) 10(5):327–329. doi:10.1016/S0936-6555(98)80089-7
Carbone A (2003) Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol 4(1):22–29. doi:10.1016/S1470-2045(03)00957-4
Carbone A, Gloghini A, Gaidano G (2004) Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 28(11):1538–1540. author reply 1540. doi:10.1097/01.pas.0000131533.21345.1c
Carbone A, Gloghini A, Gaidano G (2008) KSHV/HHV8 doesn’t play a significant role in the development of plasmablastic lymphoma of the oral cavity. Am J Surg Pathol 32(1):172–174
Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS (2002) Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298(5597):1432–1435. doi:10.1126/science.1074883
Chetty R, Hlatswayo N, Muc R, Sabaratnam R, Gatter K (2003) Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology 42(6):605–609. doi:10.1046/j.1365-2559.2003.01636.x
Cioc AM, Allen C, Kalmar JR, Suster S, Baiocchi R, Nuovo GJ (2004) Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 28(1):41–46. doi:10.1097/00000478-200401000-00003
The Non-Hodgkin’s Lymphoma Classification Project (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood 89(11):3909–3918
Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez-Guillermo A et al (2004) Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 28(6):736–747. doi:10.1097/01.pas.0000126781.87158.e3
Dawson MA, Schwarer AP, McLean C, Oei P, Campbell LJ, Wright E et al (2007) AIDS-related plasmablastic lymphoma of the oral cavity associated with an IGH/MYC translocation–treatment with autologous stem-cell transplantation in a patient with severe haemophilia-A. Haematologica 92(1):e11–e12. doi:10.3324/haematol.10933
Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89(4):1413–1420
Deloose ST, Smit LA, Pals FT, Kersten MJ, van Noesel CJ, Pals ST (2005) High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 19(5):851–855. doi:10.1038/sj.leu.2403709
Dong HY, Scadden DT, de Leval L, Tang Z, Isaacson PG, Harris NL (2005) Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein–Barr virus-associated extramedullary plasmacytic neoplasm. Am J Surg Pathol 29(12):1633–1641. doi:10.1097/01.pas.0000173023.02724.1f
Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D et al (2000) HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95(4):1406–1412
Flaitz CM, Nichols CM, Walling DM, Hicks MJ (2002) Plasmablastic lymphoma: an HIV-associated entity with primary oral manifestations. Oral Oncol 38(1):96–102. doi:10.1016/S1368-8375(01)00018-5
Foltyn W, Kos-Kudla B, Sieminska L, Zemczak A, Strzelczyk J, Marek B et al (2006) Unique case of caecum plasmablastic lymphoma CD138(+) in patient with late diagnosed colon neuroendocrine carcinoma. Endokrynol Pol 57(2):160–165
Gessain A, Sudaka A, Briere J, Fouchard N, Nicola MA, Rio B et al (1996) Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman’s disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood 87(1):414–416
Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Tumors of hematopoietic and lymphoid tissues. IARC, Lyon
Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, Wooster R et al (2003) Kaposi’s sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci U S A 100(18):10399–10404. doi:10.1073/pnas.1630810100
Kuhnen C, Schneele H, Muller KM (1994) Malignant lymphoma and colon carcinoma 3 years after heart transplantation and immunosuppression. Pathologe 15(2):129–133. doi:10.1007/s002920050036
Lester R, Li C, Phillips P, Shenkier TN, Gascoyne RD, Galbraith PF et al (2004) Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 45(9):1881–1885. doi:10.1080/10428190410001697395
Li H, Wang H, Nicholas J (2001) Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling. J Virol 75(7):3325–3334. doi:10.1128/JVI.75.7.3325-3334.2001
Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM (2005) AIDS-related Burkitt’s lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23(19):4430–4438. doi:10.1200/JCO.2005.11.973
Lin F, Zhang K, Quiery AT Jr, Prichard J, Schuerch C (2004) Plasmablastic lymphoma of the cervical lymph nodes in a human immunodeficiency virus-negative patient: a case report and review of the literature. Arch Pathol Lab Med 128(5):581–584
Lin O, Gerhard R, Zerbini MC, Teruya-Feldstein J (2005) Cytologic features of plasmablastic lymphoma. Cancer 105(3):139–144. doi:10.1002/cncr.21036
Liu W, Lacouture ME, Jiang J, Kraus M, Dickstein J, Soltani K et al (2006) KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman’s disease and Kaposi’s sarcoma. J Cutan Pathol 33(Suppl 2):46–51. doi:10.1111/j.1600-0560.2006.00539.x
Masgala A, Christopoulos C, Giannakou N, Boukis H, Papadaki T, Anevlavis E (2007) Plasmablastic lymphoma of visceral cranium, cervix and thorax in an HIV-negative woman. Ann Hematol 86(8):615–618. doi:10.1007/s00277-007-0280-z
Matthews GV, Bower M, Mandalia S, Powles T, Nelson MR, Gazzard BG (2000) Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy. Blood 96(8):2730–2734
Nasta SD, Carrum GM, Shahab I, Hanania NA, Udden MM (2002) Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy. Leuk Lymphoma 43(2):423–426. doi:10.1080/10428190290006260
Nguyen DD, Loo BW Jr, Tillman G, Natkunam Y, Cao TM, Vaughan W et al (2003) Plasmablastic lymphoma presenting in a human immunodeficiency virus-negative patient: a case report. Ann Hematol 82(8):521–525. doi:10.1007/s00277-003-0684-3
Panos G, Karveli EA, Nikolatou O, Falagas ME (2007) Prolonged survival of an HIV-infected patient with plasmablastic lymphoma of the oral cavity. Am J Hematol 82(8):761–765. doi:10.1002/ajh.20807
Porter SR, Diz Dios P, Kumar N, Stock C, Barrett AW, Scully C (1999) Oral plasmablastic lymphoma in previously undiagnosed HIV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87(6):730–734. doi:10.1016/S1079-2104(99)70170-8
Pruneri G, Graziadei G, Ermellino L, Baldini L, Neri A, Buffa R (1998) Plasmablastic lymphoma of the stomach. A case report. Haematologica 83(1):87–89
Ramalingam P, Nayak-Kapoor A, Reid-Nicholson M, Crawford J, Ustun C (2008) Plasmablastic lymphoma with small lymphocytic lymphoma: clinico-pathologic features, and review of the literature. Leuk Lymphoma 18:1–4
Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B et al (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin’s lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19(8):2171–2178
Reece DE (2007) Management of multiple myeloma: the changing landscape. Blood Rev 21(6):301–314. doi:10.1016/j.blre.2007.07.001
Reid-Nicholson M, Kavuri S, Ustun C, Crawford J, Nayak-Kapoor A, Ramalingam P (2008) Plasmablastic lymphoma: cytologic findings in 5 cases with unusual presentation. Cancer (in press)
Riedel DJ, Gonzalez-Cuyar LF, Zhao XF, Redfield RR, Gilliam BL (2008) Plasmablastic lymphoma of the oral cavity: a rapidly progressive lymphoma associated with HIV infection. Lancet Infect Dis 8(4):261–267. doi:10.1016/S1473-3099(08)70067-7
Robak T, Urbanska-Rys H, Strzelecka B, Krykowski E, Bartkowiak J, Blonski JZ et al (2001) Plasmablastic lymphoma in a patient with chronic lymphocytic leukemia heavily pretreated with cladribine (2-CdA): an unusual variant of Richter’s syndrome. Eur J Haematol 67(5–6):322–327. doi:10.1034/j.1600-0609.2001.00592.x
Shuangshoti S, Assanasen T, Lerdlum S, Srikijvilaikul T, Intragumtornchai T, Thorner PS (2007) Primary central nervous system plasmablastic lymphoma in AIDS. Neuropathol Appl Neurobiol 34:245–247
Song J, Ohkura T, Sugimoto M, Mori Y, Inagi R, Yamanishi K et al (2002) Human interleukin-6 induces human herpesvirus-8 replication in a body cavity-based lymphoma cell line. J Med Virol 68(3):404–411. doi:10.1002/jmv.10218
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P et al (1995) Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86(4):1276–1280
Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M et al (2004) CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15(11):1673–1679. doi:10.1093/annonc/mdh399
Vega F, Chang CC, Medeiros LJ, Udden MM, Cho-Vega JH, Lau CC et al (2005) Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 18(6):806–815. doi:10.1038/modpathol.3800355
Verma S, Nuovo GJ, Porcu P, Baiocchi RA, Crowson AN, Magro CM (2005) Epstein–Barr virus- and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol 32(1):35–39. doi:10.1111/j.0303-6987.2005.00258.x
Acknowledgement
We would like to acknowledge Teresa Coleman, MD and David Deremer, Pharm D for their contribution in editing the paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ustun, C., Reid-Nicholson, M., Nayak-Kapoor, A. et al. Plasmablastic lymphoma: CNS involvement, coexistence of other malignancies, possible viral etiology, and dismal outcome. Ann Hematol 88, 351–358 (2009). https://doi.org/10.1007/s00277-008-0601-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0601-x